Clinical Trial Update: Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial compared HD203 to Enbrel in rheumatoid arthritis to evaluate equivalence in efficacy and safety; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• HD203

Snippet

Sponsor: Hanwha Chemical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED